Oscar Health, Inc.
NYSE:OSCRMedical - Healthcare Plans
+$0.05 today
- Market cap
- $7.15B
- Beta
- 2.39
- P/E (TTM)
- -214.2
- EPS (TTM)
- -$0.13
Volume 7.38M
Average 7.51M
OSCR Purchases of Investments
Cash used to buy marketable securities and other investments.
Oscar Health, Inc.NYSE: OSCR
Purchases of Investments · Q2 FY2026 · quarter ended Jun 2026
Purchases of investments growth accelerates
Q2 FY2026 purchases of investments of $4.03B (cash outflow) rose 1386.5% year over year, ahead of the +288.1% change in trailing-twelve-month purchases of investments. Sequentially, it rose 340.3% from the prior quarter. Over 3 fiscal years it compounded at -5.3% a year.
Context
- Purchases of investments amounted to 8.7% of revenue in FY2025, down 14.6 pp from a year earlier.
- Purchases of investments grew in size in 1 of the last 3 fiscal years.
What to watch
Whether quarterly growth of +1386.5% holds above the trailing-twelve-month pace of +288.1%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Purchases of Investments history
USD · from the cash flow
- Latest · FY2025
- (1.01B) USD
- Year-over-year change
- +52.5%
| Period | Period end | Purchases of Investments | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (1.01B) | +52.5% |
| FY2024 | 2024-12-31 | (2.13B) | -154.9% |
| FY2023 | 2023-12-31 | (836.98M) | +29.8% |
| FY2022 | 2022-12-31 | (1.19B) | +34.1% |
| FY2021 | 2021-12-31 | (1.81B) | — |
Purchases of Investments vs competitors
How OSCR compares with its peers on the latest reported figures
- OSCR's LTM Jun 2026 purchases of investments of $5.35B is the 3rd largest of the 8 companies compared; the peer median is $3.28B.
- Its year-over-year change of +288.1% is the 2nd highest of 8, against a peer median of +1.9%.
- Purchases of investments amounts to 34.9% of revenue for OSCR, versus a peer median of 3.2%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $16.53B | +6.0% | +24.7% | 4.0% | |
| LTM Sep 2026 | $8.84B | -43.2% | -15.5% | 4.4% | |
| LTM Jun 2026 | $5.35B | +288.1% | -5.3% | 34.9% | |
| LTM Sep 2026 | $3.7B | +411.0% | +18.6% | 1.3% | |
| LTM Jun 2026 | $3.28B | -55.4% | -12.3% | 1.7% | |
| LTM Sep 2026 | $1.39B | +85.2% | -26.8% | 3.2% | |
| LTM Jun 2026 | $213.32M | +1.9% | -17.8% | 8.6% | |
| LTM Mar 2026 | $58.33M | -25.7% | +185.3% | 1.4% | |
| Peer median (excluding OSCR) | $3.28B | +1.9% | -12.3% | 3.2% | |
Competitors are the stored peer set for OSCR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (571.43M) | (609.55M) | (270.59M) | 26.12M | (442.9M) |
| Depreciation & Amortization | 14.61M | 15.28M | 30.69M | 32.15M | 28.89M |
| Deferred Income Tax | (101K) | (165K) | 58K | (2.34M) | 2.45M |
| Stock-Based Compensation | 86.3M | 112.33M | 159.68M | 109.82M | 87.65M |
| Change in Working Capital | 247.7M | 855M | (192.09M) | 838.86M | 1.46B |
| Accounts Receivables | 80.45M | (551.15M) | 636.23M | (177.52M) | 98.57M |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | (39.46M) | 280.23M | (395.81M) | 133.09M | 167.72M |
| Other Working Capital | 206.71M | 1.13B | (432.51M) | 883.29M | 1.19B |
| Other Non-Cash Items | 41.19M | 7.46M | 86K | (26.42M) | (40.24M) |
| Operating Cash Flow | (181.75M) | 380.35M | (272.16M) | 978.19M | 1.09B |
| Capital Expenditures | (25.89M) | (29.01M) | (25.58M) | (27.9M) | (36.37M) |
| Acquisitions (Net) | 7.23M | 0 | 0 | 0 | 0 |
| Purchases of Investments | (1.81B) | (1.19B) | (836.98M) | (2.13B) | (1.01B) |
| Sales of Investments | 1.05B | 994.08M | 1.44B | 770.04M | 804.96M |
| Other Investing Activities | (555K) | 1.12M | (2.28M) | 3.93M | 4.28M |
| Investing Cash Flow | (774.52M) | (226.52M) | 577.19M | (1.39B) | (241.06M) |
| Debt Repayment | (153.17M) | 305M | 0 | 0 | 348.21M |
| Common Stock Issued | 1.35B | 1.3M | 3.96M | 68.39M | 55.03M |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 43.56M | (5.19M) | 2.49M | 0 | (4.04M) |
| Financing Cash Flow | 1.24B | 301.11M | 6.45M | 68.39M | 399.21M |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | 282.45M | 454.94M | 311.47M | (340.85M) | 1.25B |
| Free Cash Flow | (207.63M) | 351.34M | (297.74M) | 950.3M | 1.06B |
Oscar Health, Inc.
NYSE:OSCR
Intrinsic Alpha fair value
Locked
Current Price
$27.57
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.